CLINICAL_TRIALS
trial_result
· 2010-10-04
Clinical Trial Update: SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study [Phase 2, Phase 3]
Summary
Update on a Phase II/III trial evaluating the optimal drospirenone dose versus placebo for dysmenorrhea; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Dysmenorrhea | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2010-10-04